Frontlight ResearchEarly access
TerminatedNo phase
Mechanisms of Exacerbation of Asthma
Key facts
- Who runs it
- University of California, San Francisco
- Where
- San Francisco, United StatesSee the site
- Trial code
- Status
- Terminated
- People taking part
- 67 people enrolled
- Started
- May 2006
- Ended
- 5 Aug 2025
- Type of study
- Observational
- Record updated
- 9 March 2026
- Why it stopped
- The restrictions on research imposed for the COVID-19 pandemic prevented us from continuing recruitment and visits. Funding was not sufficient to continue the study.
Who can take part
- Age
- 18 years to 75 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (7)Hide the full registry criteria
Who can take part
- Male and female subjects with a history of asthma between the ages of 18 to 75 years
- Physician diagnosis of asthma
- Currently experiencing an acute exacerbation of asthma. This exacerbation may be severe necessitating treatment in the emergency room, ICU, or hospital ward
- Ability to provide informed consent
Who cannot take part
- Use of recreational drugs in the 1 month preceding the study
- Lung disease other than asthma
- Females who are lactating or who are pregnant
Where in United States
- UCSF Airway Clinical Research CenterSan Francisco, United States
About the trial
What the trial wants to find out
The purpose of this study is to identify the causes of asthma that were not previously suspected, to better understand the effects of inhaled steroids on asthma and to identify new way to treat asthma.
The group in the trial
- Asthma
People who have been diagnosed with Asthma
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 9 March 2026